Skip to content
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d3372f25-f88e-440b-9135-ef1d3beb7a83&Preview=1
-
Date
7/27/2010
-
Company Name
Great Lakes Pharmaceuticals
-
Mailing Address
2000 Auburn Dr. Beachwood, OH 44122
-
Company Description
Great Lakes is a clinical-stage company focused on eliminating microbial infections associated with biofilm formation.
-
Website
http://www.glpharma.com
-
Transaction Type
Venture Equity
-
Transaction Amount
$3,100,000
-
Transaction Round
Series B
-
Proceeds Purposes
The Company intends to use the funds to complete a pivotal clinical study of B-Lock, an antimicrobial catheter lock solution.
-
M&A Terms
-
Venture Investor
Charter Life Sciences Fund
-
Venture Investor
Early Stage Partners, LP
-
Venture Investor
Ohio TechAngels Fund
-
Venture Investor
North Coast Angel Fund